FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/04/032978 [Registered on: 20/04/2021] Trial Registered Prospectively
Last Modified On: 23/08/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [VIRECHANA KARMA & UDARDA PRASHAMANA MAHAKASHAYA CHURNA]  
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   THERAPEUTIC PURGATION IN SKIN DISEASE 
Scientific Title of Study   A CLINICAL STUDY TO EVALUATE THE EFFICACY OF VIRECHANA KARMA AND UDARDA PRASHAMANA MAHAKASHAYA IN SHEETAPITTA W.S.R TO URTICARIA 
Trial Acronym  UDVISHEE 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR SHUBHAM MAHESHWARI 
Designation  M.D SCHOLAR, PANCHAKARMA DEPARTMENT 
Affiliation  GOVERNMENT P.G. AYURVEDA COLLEGE AND HOSPITAL, VARANASI 
Address  GOVERNMENT P.G. AYURVEDA COLLEGE AND HOSPITAL, CHAUKHAGHAT, VARANASI

Varanasi
UTTAR PRADESH
221002
India 
Phone  8279749968  
Fax    
Email  docshubham.mah@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR SHUBHAM MAHESHWARI 
Designation  M.D SCHOLAR, PANCHAKARMA DEPARTMENT 
Affiliation  GOVERNMENT P.G. AYURVEDA COLLEGE AND HOSPITAL, VARANASI 
Address  GOVERNMENT P.G. AYURVEDA COLLEGE AND HOSPITAL, CHAUKHAGHAT, VARANASI


UTTAR PRADESH
221002
India 
Phone  8279749968  
Fax    
Email  docshubham.mah@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR SHUBHAM MAHESHWARI 
Designation  M.D SCHOLAR, PANCHAKARMA DEPARTMENT 
Affiliation  GOVERNMENT P.G. AYURVEDA COLLEGE AND HOSPITAL, VARANASI 
Address  GOVERNMENT P.G. AYURVEDA COLLEGE AND HOSPITAL, CHAUKHAGHAT, VARANASI


UTTAR PRADESH
221002
India 
Phone  8279749968  
Fax    
Email  docshubham.mah@gmail.com  
 
Source of Monetary or Material Support  
GOVERNMENT P.G. AYURVEDA COLLEGE AND HOSPITAL, VARANASI 
 
Primary Sponsor  
Name  Government PG Ayurveda College And Hospital Varanasi 
Address  Government P.G. Ayurveda College And Hospital, Chaukhaghat, Varanasi 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
nil  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Manish Mishra  GOVERNMENT P.G. AYURVEDA COLLEGE AND HOSPITAL, VARANASI  DEPARTMENT OF KAYA CHIKITSA AND PANCHAKARMA, GOVERNMENT P.G. AYURVEDA COLLEGE AND HOSPITAL, CHAUKHAGHAT, VARANASI
Varanasi
UTTAR PRADESH 
9415896482

manish.arnav@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC Government Post Graduate Ayurvedic College and Hospital Sampurnanand Sanskrit University Varanasi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L500||Allergic urticaria. Ayurveda Condition: Sheetapitta,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  UDARDA PRASHAMANA MAHAKASHAYA IN SHEETAPITTA  5gm UDARDA PRASHAMANA MAHAKASHAYA CHURNA WITH LUKE WARM WATER TWICE A DAY 
Comparator Agent  VIRECHANA KARMA AND UDARDA PRASHAMANA MAHAKASHAYA IN SHEETAPITTA  30-50ML ERANDA TAIL WITH DOUBLE AMOUNT TRIPHALA KWATH ALONG WITH 5gm UDARDA PRASHAMANA MAHAKASHAYA CHURNA WITH LUKE WARM WATER TWICE A DAY 
Intervention  VIRECHANA KARMA WITH ERANDA TAIL AND TRIPHALA KWATH IN SHEETAPITTA  30-50ML ERANDA TAIL WITH DOUBLE AMOUNT TRIPHALA KWATH 
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  PATIENTS WITH CLASSICAL SYMPTOMS OF SHEETAPITTA viz. MANDALA UTSEDHA, TODA, DAHA, KANDU, CHHARDI.
VIRECHANA ARHA PATIENTS 
 
ExclusionCriteria 
Details  HISTORY OF ANAPHYLAXIS TO MODERN MEDICINE PRESCRIBED FOR URTICARIA.
PATIENTS HAVING HISTORY OF ANY CHRONIC OR SYSTEMIC ILLNESS eg. HEART DISEASE, PARAPLASIA, TB, DIABETES, JAUNDICE, PREGNANT WOMEN, ANGIOEDEMA, LEPROSY, ECZEMA, FUNGAL INFECTION AND OTHER SKIN DISEASE. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
RELIEF IN ITCHING AND RASHES  10 DAYS 
 
Secondary Outcome  
Outcome  TimePoints 
NO RELAPSE OF SYMPTOMS  45 DAYS 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "60"
Final Enrollment numbers achieved (India)="60" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/05/2021 
Date of Study Completion (India) 12/05/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Publication: World Journal of Pharmaceutical research Title: URTICARIA: AN AYURVEDIC POINT OF VIEW DOI: 10.20959/wjpr202111-21344 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
This Study is a randomized, Multiple arm  group study trial comparing the efficacy of Virechana Karma and Udarda Prashamana Mahakashya in Sheetapitta (Urticaria). Patients will be randomly selected from OPD and
IPD of Department of Panchakarma, Government PG Ayurveda College and Hospital, Varanasi.
60 Patients will be studied under 3 groups having 20 patients in each group:
Group 1: Virechana Karma by Eranda Tail with Triphala Kwath will be given approximate for 21 days.
Group 2: Udarda Prashamana Mahakashya Churna (5 gm bid with luke warm water) will be given  for 21 days.
Group 3: Virechana Karma along with Udarda Prashamana Mahakashya Churna (5 gm bid with luke warm water) for 21 days.
Follow up will be done after every 15 days of treatment in each group
Statistical method of Analysis: The parameters of baseline data will be compared with the follow up status for assessment of results.
 
Close